Results 91 to 100 of about 5,828,957 (159)

004 Post Finasteride Syndrome: is Dutasteride Unfairly Accused?

The Journal of Sexual Medicine, 2016
W. Baas, M.J. Butcher, K. Delfino, A. Lwin, B. Holland, M. Herberts, J. Clemons, S. Althof, T.S. Kohler, K.T. McVary   +9 more
openaire   +1 more source

Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review. [PDF]

Front Med (Lausanne)
Złotowska A, Jastrząb-Miśkiewicz B, Krajewski PK.   +2 more
europepmc   +1 more source

FINASTERIDE-ASSOCIATED MALE INFERTILITY

, 2004
Finasteride is a potent and specific inhibitor of the 5α-reductase enzyme in men. Clinical studies have shown that finasteride 1mg/day is effective for promoting hair growth in men with male pattern hair loss. However, there is a concern about the use of
Saade, Ricardo, Galuppo, Andrea Giannotti, Einstein Jewich, Jonathas Borges Soares, Neves, Paulo Augusto, Paulo Augusto Neves, Ricardo Saade, Nelson Rodrigues, Netto Jr., Nelson Rodrigues, Sidney Glina, Glina, Sidney, Hospital São Paulo/sp, Soares, Jonathas Borges   +12 more
core  

Diet-Induced Obesity Promotes Alopecia Through Oxidative Stress and Androgen Signalling in Female Mice. [PDF]

Exp Dermatol
Tu YA, Chou CH, Chang K, Huang CC, Ho HN, Chen MJ.   +5 more
europepmc   +1 more source

Steroid 5α-reductases in the brain: From neurosteroidogenesis to therapeutic implications. [PDF]

Front Neuroendocrinol
Braccagni G, Branca C, Bortolato M.
europepmc   +1 more source

Persistent Sexual and Psychological Symptoms After Finasteride Discontinuation: A Cross-Sectional Observational Study. [PDF]

J Clin Med
Jędrzejczyk P, Ząbkowski T, Ratajski J, Ciechan K, Kaminski TW, Uciechowski P, Syryło T.   +6 more
europepmc   +1 more source

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management. [PDF]

Medicina (Kaunas)
Roidos C, Sountoulides P, Papathanasiou K, Symeonidis A, Mykoniatis I.   +4 more
europepmc   +1 more source

Targeting Aromatase and 5-α-Reductase to Limit Dysfunctional Adipogenesis in Multiple Symmetric Lipomatosis. [PDF]

Biomedicines
Milan G, Compagnin C, Zucal I, Perale G, Bettini S, Pilatone A, De Monti M, Harder Y, Parodi C, Schmauss D, Vindigni V, Bassetto F, Felthaus O, Oliinyk D, Prantl L, Busetto L.   +15 more
europepmc   +1 more source

Primary care approach to alopecia in adult patients. [PDF]

Singapore Med J
Cheung YS, Ng IKS, Long VS, Goh LH, Chandran NS.   +4 more
europepmc   +1 more source

VEXAS syndrome presenting with severe cutaneous manifestations, inflammatory arthritis, and myelodysplastic syndrome treated with Ruxolitinib. [PDF]

Oxf Med Case Reports
Tesch J, Alrifai N, Honl B, Singhal S.
europepmc   +1 more source